Bristol-Myers upgraded at UBS: UBS said it is upgrading BMY to Neutral from Reduce after Plavix patent case was settled. Raised target price to $24.50 from $20. Bristol-Meyers upgraded at Morgan Stanley: Morgan Stanley said it is increasing its rating on BMY to Equalweight from Underweight. Target raised to $25 a share from $23 a share. Jones Apparel Group downgraded at Prudential: Prudential said it is downgrading JNY to a Neutral Weight rating, and raising its target price to $38 to reflect possible sale of company.
STOCK COMMENTS / EPS CHANGES
Alpharma estimates raised at Morgan Stanley: Morgan Stanley said it is increasing its estimates on ALO to $1.45 a share from $1.44 a share. Maintained Underweight rating. AMR estimates raised at Goldman: Goldman said it is increasing its estimates on AMR to a loss of 50 cents a share in 2006 from a loss of $1.10 a share due to strong revenues. BEA Systems target raised at Jefferies: Jefferies said it was raising the target on BEAS from $12.50 to $14 following the company's annual analyst day. Maintained Buy rating. Biomet estimates cut at Morgan Stanley: Morgan Stanley said it is lowering its estimates on BMET for the full year to $1.68 a share from $1.72 a share. Maintained Overweight rating. Comcast estimates cut at Goldman: Goldman said it is lowering its estimates on CMCSA for the full year to 78 cents a share from 82-cents a share. Maintained Inline rating. FactSet estimates raised at Piper: Piper said it is raising its 2006 estimates on FDS by 2 cents to $1.53 a share due to better than expected subscription revenue. FactSet estimates raised at Morgan Stanley: Morgan Stanley said it is increasing its estimates on FDS for the full year to $1.51 a share from $1.47 a share. Target price raised to $46 a share. Maintained Overweight rating.